Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(13):1042-1053; doi:10.1093/jnci/92.13.1042
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Costantini, P.
Right arrow Articles by Kroemer, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Costantini, P.
Right arrow Articles by Kroemer, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 13, 1042-1053, July 5, 2000
© 2000 Oxford University Press


REVIEW

Mitochondrion as a Novel Target of Anticancer Chemotherapy

Paola Costantini, Etienne Jacotot, Didier Decaudin, Guido Kroemer

Affiliations of authors: P. Costantini, E. Jacotot, G. Kroemer, Centre National de la Recherche Scientifique, Institut Gustave Roussy, Villejuif, France; D. Decaudin, Institut Curie, Département d'Hématologie, Paris, France.

Correspondence to: Guido Kroemer, M.D., Ph.D., 19 rue Guy Môquet, B.P. 8, F-94801 Villejuif, France (e-mail: kroemer{at}infobiogen.fr).

Mitochondrial membrane permeabilization is a critical event in the process leading to physiologic or chemotherapy-induced apoptosis (programmed cell death). This permeabilization event is, at least in part, under the control of the permeability transition pore complex (PTPC). Oncoproteins from the Bcl-2 family and tumor suppressor proteins from the Bax family interact with PTPC to inhibit or facilitate membrane permeabilization, respectively. Conventional chemotherapeutic agents elicit mitochondrial permeabilization in an indirect fashion by induction of endogenous effectors that are involved in the physiologic control of apoptosis. However, an increasing number of experimental anticancer drugs, including lonidamine, arsenite, betulinic acid, CD437, and several amphipathic cationic {alpha}-helical peptides, act directly on mitochondrial membranes and/or on the PTPC. Such agents may induce apoptosis in circumstances in which conventional drugs fail to act because endogenous apoptosis induction pathways, such as those involving p53, death receptors, or apical caspase activation, are disrupted. However, stabilization of the mitochondrial membrane by antiapoptotic Bcl-2-like proteins reduces the cytotoxic potential of most of these drugs. Targeting of specific PTPC components may overcome this Bcl-2-mediated apoptosis inhibition. One strategy involves cross-linking of critical redox-sensitive thiol groups within the PTPC; another involves the use of ligands to the mitochondrial benzodiazepine receptor. Thus, the design of mitochondrion-targeted cytotoxic drugs may constitute a novel strategy for overcoming apoptosis resistance.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
M. L. Heaney, J. R. Gardner, N. Karasavvas, D. W. Golde, D. A. Scheinberg, E. A. Smith, and O. A. O'Connor
Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs
Cancer Res., October 1, 2008; 68(19): 8031 - 8038.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
W. Kim, J.-H. Yoon, J.-M. Jeong, G.-J. Cheon, T.-S. Lee, J.-I. Yang, S.-C. Park, and H.-S. Lee
Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma
Mol. Cancer Ther., September 1, 2007; 6(9): 2554 - 2562.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Rege, S. J. Patel, Z. Megeed, and M. L. Yarmush
Amphipathic Peptide-Based Fusion Peptides and Immunoconjugates for the Targeted Ablation of Prostate Cancer Cells
Cancer Res., July 1, 2007; 67(13): 6368 - 6375.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
B. Law, L. Quinti, Y. Choi, R. Weissleder, and C.-H. Tung
A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity.
Mol. Cancer Ther., August 1, 2006; 5(8): 1944 - 1949.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Wang, Z. Li, Y. Lu, R. Du, S. Katiyar, J. Yang, M. Fu, J. E. Leader, A. Quong, P. M. Novikoff, et al.
Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function
PNAS, August 1, 2006; 103(31): 11567 - 11572.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Sakamaki, M. C. Casimiro, X. Ju, A. A. Quong, S. Katiyar, M. Liu, X. Jiao, A. Li, X. Zhang, Y. Lu, et al.
Cyclin d1 determines mitochondrial function in vivo.
Mol. Cell. Biol., July 1, 2006; 26(14): 5449 - 5469.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Hartel, F F di Mola, F Selvaggi, G Mascetta, M N Wente, K Felix, N A Giese, U Hinz, P Di Sebastiano, M W Buchler, et al.
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management
Gut, April 1, 2006; 55(4): 519 - 528.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Kluza, M.-A. Gallego, A. Loyens, J.-C. Beauvillain, J.-M. F. Sousa-Faro, C. Cuevas, P. Marchetti, and C. Bailly
Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin d.
Cancer Res., March 15, 2006; 66(6): 3177 - 3187.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Kim, J. J. Song, J. Y. An, Y. T. Kwon, and Y. J. Lee
Pretreatment of Acetylsalicylic Acid Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis by Down-regulating BCL-2 Gene Expression
J. Biol. Chem., December 9, 2005; 280(49): 41047 - 41056.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Gago-Dominguez, J. E. Castelao, M. C. Pike, A. Sevanian, and R. W. Haile
Role of Lipid Peroxidation in the Epidemiology and Prevention of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2829 - 2839.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. E. Furre, S. Shahzidi, Z. Luksiene, M. T.N. Moller, E. Borgen, J. Morgan, K. Tkacz-Stachowska, J. M. Nesland, and Q. Peng
Targeting PBR by Hexaminolevulinate-Mediated Photodynamic Therapy Induces Apoptosis through Translocation of Apoptosis-Inducing Factor in Human Leukemia Cells
Cancer Res., December 1, 2005; 65(23): 11051 - 11060.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. R. Fantin, M. J. Berardi, H. Babbe, M. V. Michelman, C. M. Manning, and P. Leder
A Bifunctional Targeted Peptide that Blocks HER-2 Tyrosine Kinase and Disables Mitochondrial Function in HER-2-Positive Carcinoma Cells
Cancer Res., August 1, 2005; 65(15): 6891 - 6900.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Ceruti, A. Mazzola, and M. P. Abbracchio
Resistance of Human Astrocytoma Cells to Apoptosis Induced by Mitochondria-Damaging Agents: Possible Implications for Anticancer Therapy
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 825 - 837.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C.-C. Wu, M.-L. Chan, W.-Y. Chen, C.-Y. Tsai, F.-R. Chang, and Y.-C. Wu
Pristimerin induces caspase-dependent apoptosis in MDA-MB-231 cells via direct effects on mitochondria
Mol. Cancer Ther., August 1, 2005; 4(8): 1277 - 1285.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Lievre, C. Chapusot, A.-M. Bouvier, F. Zinzindohoue, F. Piard, P. Roignot, L. Arnould, P. Beaune, J. Faivre, and P. Laurent-Puig
Clinical Value of Mitochondrial Mutations in Colorectal Cancer
J. Clin. Oncol., May 20, 2005; 23(15): 3517 - 3525.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Z. Cheng, R. C. Winant, and S. S. Gambhir
A New Strategy to Screen Molecular Imaging Probe Uptake in Cell Culture Without Radiolabeling Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
J. Nucl. Med., May 1, 2005; 46(5): 878 - 886.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Hu, C. Jiang, C. Ip, Y. M. Rustum, and J. Lu
Methylseleninic Acid Potentiates Apoptosis Induced by Chemotherapeutic Drugs in Androgen-Independent Prostate Cancer Cells
Clin. Cancer Res., March 15, 2005; 11(6): 2379 - 2388.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Rotem, A. Heyfets, O. Fingrut, D. Blickstein, M. Shaklai, and E. Flescher
Jasmonates: Novel Anticancer Agents Acting Directly and Selectively on Human Cancer Cell Mitochondria
Cancer Res., March 1, 2005; 65(5): 1984 - 1993.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. B. Ambrosone, J. Ahn, K. K. Singh, H. Rezaishiraz, H. Furberg, C. Sweeney, B. Coles, and A. Trovato
Polymorphisms in Genes Related to Oxidative Stress (MPO, MnSOD, CAT) and Survival After Treatment for Breast Cancer
Cancer Res., February 1, 2005; 65(3): 1105 - 1111.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
X. Liu, P. Yue, Z. Zhou, F. R. Khuri, and S.-Y. Sun
Death Receptor Regulation and Celecoxib-Induced Apoptosis in Human Lung Cancer Cells
J Natl Cancer Inst, December 1, 2004; 96(23): 1769 - 1780.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. E. Denlinger, B. K. Rundall, and D. R. Jones
Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species
J. Thorac. Cardiovasc. Surg., November 1, 2004; 128(5): 740 - 748.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. Liang, R. A. Salinas, B. Z. Leal, T. Kosakowska-Cholody, C. J. Michejda, S. J. Waters, T. S. Herman, J. M. Woynarowski, and B. A. Woynarowska
Caspase-mediated apoptosis and caspase-independent cell death induced by irofulven in prostate cancer cells
Mol. Cancer Ther., November 1, 2004; 3(11): 1385 - 1396.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
N. L. Krett, K. M. Davies, M. Ayres, C. Ma, C. Nabhan, V. Gandhi, and S. T. Rosen
8-Amino-adenosine is a potential therapeutic agent for multiple myeloma
Mol. Cancer Ther., November 1, 2004; 3(11): 1411 - 1420.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. N. Ivanov and T. K. Hei
Arsenite Sensitizes Human Melanomas to Apoptosis via Tumor Necrosis Factor {alpha}-mediated Pathway
J. Biol. Chem., May 21, 2004; 279(21): 22747 - 22758.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S.-Y. Sun, N. Hail Jr, and R. Lotan
Apoptosis as a Novel Target for Cancer Chemoprevention
J Natl Cancer Inst, May 5, 2004; 96(9): 662 - 672.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. G. Keedwell, Y. Zhao, L. A. Hammond, S. Qin, K.-Y. Tsang, A. Reitmair, Y. Molina, Y. Okawa, L. I. Atangan, D.-L. Shurland, et al.
A Retinoid-Related Molecule that Does Not Bind to Classical Retinoid Receptors Potently Induces Apoptosis in Human Prostate Cancer Cells through Rapid Caspase Activation
Cancer Res., May 1, 2004; 64(9): 3302 - 3312.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Schmitt, A. Parcellier, F. Ghiringhelli, N. Casares, S. Gurbuxani, N. Droin, A. Hamai, M. Pequignot, A. Hammann, M. Moutet, et al.
Increased Immunogenicity of Colon Cancer Cells by Selective Depletion of Cytochrome c
Cancer Res., April 15, 2004; 64(8): 2705 - 2711.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Hagg, M. Berndtsson, A. Mandic, R. Zhou, M. C. Shoshan, and S. Linder
Induction of endoplasmic reticulum stress by ellipticine plant alkaloids
Mol. Cancer Ther., April 1, 2004; 3(4): 489 - 497.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Schubert and S. Grimm
Cyclophilin D, a Component of the Permeability Transition-Pore, Is an Apoptosis Repressor
Cancer Res., January 1, 2004; 64(1): 85 - 93.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. R. Fantin and P. Leder
F16, a Mitochondriotoxic Compound, Triggers Apoptosis or Necrosis Depending on the Genetic Background of the Target Carcinoma Cell
Cancer Res., January 1, 2004; 64(1): 329 - 336.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Garattini, E. Parrella, L. Diomede, M. Gianni', Y. Kalac, L. Merlini, D. Simoni, R. Zanier, F. F. Ferrara, I. Chiarucci, et al.
ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis
Blood, January 1, 2004; 103(1): 194 - 207.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Boitano, J. A. Ellman, G. D. Glick, and A. W. Opipari Jr.
The Proapoptotic Benzodiazepine Bz-423 Affects the Growth and Survival of Malignant B Cells
Cancer Res., October 15, 2003; 63(20): 6870 - 6876.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. Papaldo, M. Lopez, E. Cortesi, E. Cammilluzzi, M. Antimi, E. Terzoli, G. Lepidini, P. Vici, C. Barone, G. Ferretti, et al.
Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide
J. Clin. Oncol., September 15, 2003; 21(18): 3462 - 3468.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. G. Rajesh, S. Sasaguri, Z. Zhitian, R. Suzuki, R. Asakai, and H. Maeda
Second window of ischemic preconditioning regulates mitochondrial permeability transition pore by enhancing Bcl-2 expression
Cardiovasc Res, August 1, 2003; 59(2): 297 - 307.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. H. Lash
The Mitochondrial Benzodiazepine Receptor as a Potential Target Protein for Drug Development: Demonstration of Functional Significance with Cell Lines Exhibiting Differential Expression of Bcl-2
Toxicol. Sci., July 1, 2003; 74(1): 1 - 3.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. E. Muscarella, K. A. O'Brien, A. T. Lemley, and S. E. Bloom
Reversal of Bcl-2-Mediated Resistance of the EW36 Human B-Cell Lymphoma Cell Line to Arsenite- and Pesticide-Induced Apoptosis by PK11195, a Ligand of the Mitochondrial Benzodiazepine Receptor
Toxicol. Sci., July 1, 2003; 74(1): 66 - 73.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Ortega, J. Carretero, E. Obrador, J. Gambini, M. Asensi, V. Rodilla, and J. M. Estrela
Tumor Cytotoxicity by Endothelial Cells. IMPAIRMENT OF THE MITOCHONDRIAL SYSTEM FOR GLUTATHIONE UPTAKE IN MOUSE B16 MELANOMA CELLS THAT SURVIVE AFTER IN VITRO INTERACTION WITH THE HEPATIC SINUSOIDAL ENDOTHELIUM
J. Biol. Chem., April 11, 2003; 278(16): 13888 - 13897.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. Berge, K. J. Tronstad, P. Bohov, L. Madsen, and R. K. Berge
Impact of mitochondrial {beta}-oxidation in fatty acid-mediated inhibition of glioma cell proliferation
J. Lipid Res., January 1, 2003; 44(1): 118 - 127.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Lansiaux, F. Tanious, Z. Mishal, L. Dassonneville, A. Kumar, C. E. Stephens, Q. Hu, W. D. Wilson, D. W. Boykin, and C. Bailly
Distribution of Furamidine Analogues in Tumor Cells: Targeting of the Nucleus or Mitochondria Depending on the Amidine Substitution
Cancer Res., December 15, 2002; 62(24): 7219 - 7229.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. F. Holmes, D. R. Soprano, and K. J. Soprano
Elucidation of Molecular Events Mediating Induction of Apoptosis by Synthetic Retinoids Using a CD437-resistant Ovarian Carcinoma Cell Line
J. Biol. Chem., November 15, 2002; 277(47): 45408 - 45419.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. Castedo, J.-L. Perfettini, and G. Kroemer
Mitochondrial Apoptosis and the Peripheral Benzodiazepine Receptor: A Novel Target for Viral and Pharmacological Manipulation
J. Exp. Med., November 4, 2002; 196(9): 1121 - 1126.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
N. Hail Jr. and R. Lotan
Examining the Role of Mitochondrial Respiration in Vanilloid-Induced Apoptosis
J Natl Cancer Inst, September 4, 2002; 94(17): 1281 - 1292.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
M. G. Fernandez, L. Troiano, L. Moretti, M. Nasi, M. Pinti, S. Salvioli, J. Dobrucki, and A. Cossarizza
Early Changes in Intramitochondrial Cardiolipin Distribution during Apoptosis
Cell Growth Differ., September 1, 2002; 13(9): 449 - 455.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Mizutani, S. Tada-Oikawa, Y. Hiraku, S. Oikawa, M. Kojima, and S. Kawanishi
Mechanism of Apoptosis Induced by a New Topoisomerase Inhibitor through the Generation of Hydrogen Peroxide
J. Biol. Chem., August 16, 2002; 277(34): 30684 - 30689.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. G. Ferreira, M. Epping, F. A. E. Kruyt, and G. Giaccone
Apoptosis: Target of Cancer Therapy
Clin. Cancer Res., July 1, 2002; 8(7): 2024 - 2034.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. M. Barrett, F. L. Lewis, J. B. Roaten, T. W. Sweatman, M. Israel, J. L. Cleveland, and L. Lothstein
Novel Extranuclear-targeted Anthracyclines Override the Antiapoptotic Functions of Bcl-2 and Target Protein Kinase C Pathways to Induce Apoptosis
Mol. Cancer Ther., May 1, 2002; 1(7): 469 - 481.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Decaudin, M. Castedo, F. Nemati, A. Beurdeley-Thomas, G. De Pinieux, A. Caron, P. Pouillart, J. Wijdenes, D. Rouillard, G. Kroemer, et al.
Peripheral Benzodiazepine Receptor Ligands Reverse Apoptosis Resistance of Cancer Cells in Vitro and in Vivo
Cancer Res., March 1, 2002; 62(5): 1388 - 1393.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Szewczyk and L. Wojtczak
Mitochondria as a Pharmacological Target
Pharmacol. Rev., March 1, 2002; 54(1): 101 - 127.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. R. Jones, R. M. Broad, L. D. Comeau, S. J. Parsons, and M. W. Mayo
Inhibition of nuclear factor {kappa}B chemosensitizes non-small cell lung cancer through cytochrome c release and caspase activation
J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 310 - 317.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Wosikowski, K. Mattern, I. Schemainda, M. Hasmann, B. Rattel, and R. Loser
WK175, a Novel Antitumor Agent, Decreases the Intracellular Nicotinamide Adenine Dinucleotide Concentration and Induces the Apoptotic Cascade in Human Leukemia Cells
Cancer Res., February 1, 2002; 62(4): 1057 - 1062.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
D. Cen, R. I. Gonzalez, J. A. Buckmeier, R. S. Kahlon, N. B. Tohidian, and F. L. Meyskens Jr
Disulfiram Induces Apoptosis in Human Melanoma Cells: A Redox-related Process
Mol. Cancer Ther., January 1, 2002; 1(3): 197 - 204.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Hail Jr. and R. Lotan
Mitochondrial Respiration Is Uniquely Associated with the Prooxidant and Apoptotic Effects of N-(4-Hydroxyphenyl)retinamide
J. Biol. Chem., November 30, 2001; 276(49): 45614 - 45621.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. A. Ruefli, M. J. Ausserlechner, D. Bernhard, V. R. Sutton, K. M. Tainton, R. Kofler, M. J. Smyth, and R. W. Johnstone
The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species
PNAS, September 4, 2001; (2001) 191208598.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Hail Jr., E. M. Youssef, and R. Lotan
Evidence Supporting a Role for Mitochondrial Respiration in Apoptosis Induction by the Synthetic Retinoid CD437
Cancer Res., September 1, 2001; 61(18): 6698 - 6702.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. N. Phenix, J. J. Lum, Z. Nie, J. Sanchez-Dardon, and A. D. Badley
Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss
Blood, August 15, 2001; 98(4): 1078 - 1085.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. M. Dirsch, H. Stuppner, and A. M. Vollmar
Helenalin Triggers a CD95 Death Receptor-independent Apoptosis That Is Not Affected by Overexpression of Bcl-xL or Bcl-2
Cancer Res., August 1, 2001; 61(15): 5817 - 5823.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Pervin, R. Singh, C.-L. Gau, H. Edamatsu, F. Tamanoi, and G. Chaudhuri
Potentiation of Nitric Oxide-induced Apoptosis of MDA-MB-468 Cells by Farnesyltransferase Inhibitor: Implications in Breast Cancer
Cancer Res., June 1, 2001; 61(12): 4701 - 4706.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. R. Dumon, H. Ishii, A. Vecchione, F. Trapasso, G. Baldassarre, F. Chakrani, T. Druck, E. F. Rosato, N. N. William